Who is the CEO of Asterasys?

According to the DART company overview, Asterasys' representative director is 서은택 (name as registered in Korean). The company was founded on 2015-07-07.

Where is Asterasys listed?

Asterasys trades on the Korea Exchange KOSDAQ market under the ticker 450950. Its fiscal year ends in December.

Does Asterasys pay a dividend?

Yes. For fiscal 2025, Asterasys paid a cash dividend of ₩105 per common share, a 0.9% yield as stated in its annual report, with a payout ratio of 43.1%. The prior year's dividend was ₩32.

Does Asterasys have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Share pledge (a 5%+ holder reported a share pledge agreement (loan, extension or change) in the past 90 days). These are factual flags, not investment advice.

Which companies are in the same industry as Asterasys?

Under the Korean Standard Industrial Classification recorded on DART, Asterasys is grouped with 11 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Noul, LivsMed and Laseroptek.

Asterasys KRX:450950KOSDAQ

아스테라시스 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h2

Articles, 7 days2

DART filings, 7 days0

Articles tracked2since Sep 11

In Q2 2026, Asterasys reported revenue of ₩11.2bn, up 8.6% year on year, and operating profit of ₩79m. Asterasys (아스테라시스) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 30 with 2 articles.

Filing signals Share pledge Screener

Asterasys quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩11.2bn	+8.6%	₩79m margin 0.7%	₩1.3bn
Q1 2026	₩7.5bn	+11.7%	−₩1.8bn margin −23.9%	−₩960m
Q4 2025 derived	₩12.2bn	+13.8%	₩3.7bn margin 30.1%	₩3.8bn
Q3 2025	₩8.8bn	+29.2%	₩2.3bn margin 26.3%	₩1.9bn
Q2 2025	₩10.3bn	+31.8%	₩3.8bn margin 37.1%	₩2.9bn
Q1 2025	₩6.7bn	+90.1%	₩591m margin 8.8%	₩524m
Q4 2024 derived	₩10.7bn	–	₩3.7bn margin 34.7%	₩3.7bn
Q3 2024	₩6.8bn	–	₩1.5bn margin 21.7%	₩1.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Asterasys top stories 2 weeks, by number of outlets

1
아스테라시스, 중남미 의료진 대상 학술교육 프로그램 진행
1 outlets · 1 articlesFirst report Oct 30 11:17 라포르시안
2
아스테라시스, 중남미 의료진 45명 초청 임상 교육
1 outlets · 1 articlesFirst report Oct 30 10:36 뉴스핌

Latest Asterasys news Korean headlines

11:17

아스테라시스, 중남미 의료진 대상 학술교육 프로그램 진행
라포르시안
10:36

아스테라시스, 중남미 의료진 45명 초청 임상 교육
뉴스핌

Articles per day 2 weeks

230

Company profile

CEO: 서은택
Industry: Medical devices
Founded: 2015-07-07
Fiscal year-end: December
Head office: 서울특별시 성동구
Website: asterasys.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Asterasys dividends annual report

Korea dividend rankings

Year	Per share	Yield	Payout
FY2025	₩105	0.9%	43.1%
FY2024	₩32	–	19.6%
FY2023	–	–	–

Major shareholders latest 5%+ report per holder

Korea 5% stake disclosures

서은택45.87%

Each holder's most recent 5% ownership report on DART; names as filed in Korean.

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
Noul	−₩4.8bn	24
LivsMed	−₩12.2bn	17
Laseroptek	−₩991m	15
Mediana	₩3.0bn	8
i-SENS	₩6.6bn	8
Mezoo	₩875m	7
SD Biosensor	−₩7.3bn	4
PJ Electronics	₩1.8bn	2

Compare Asterasys side by side with these companies

Asterasys DART filings

Sep 2917:14

5% ownership report 주식등의대량보유상황보고서(일반)
Ownership reports

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Asterasys FAQ

Who is the CEO of Asterasys?: According to the DART company overview, Asterasys' representative director is 서은택 (name as registered in Korean). The company was founded on 2015-07-07.
Where is Asterasys listed?: Asterasys trades on the Korea Exchange KOSDAQ market under the ticker 450950. Its fiscal year ends in December.
What were Asterasys' latest quarterly results?: In Q2 2026, Asterasys reported revenue of ₩11.2bn, up 8.6% year on year, and operating profit of ₩79m. Figures come from reports filed on DART.
Does Asterasys pay a dividend?: Yes. For fiscal 2025, Asterasys paid a cash dividend of ₩105 per common share, a 0.9% yield as stated in its annual report, with a payout ratio of 43.1%. The prior year's dividend was ₩32.
Does Asterasys have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Share pledge (a 5%+ holder reported a share pledge agreement (loan, extension or change) in the past 90 days). These are factual flags, not investment advice.
Which companies are in the same industry as Asterasys?: Under the Korean Standard Industrial Classification recorded on DART, Asterasys is grouped with 11 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Noul, LivsMed and Laseroptek.